Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement Effects on HDL in Hypogonadism
NCT01454011Phase 4Completed
- Sponsor
- Gulhane School of Medicine
- Start
- Sep 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Testosterone TEPI patch in Congenital Hypogonadotropic Hypogonadism (CHH), sponsored by Gulhane School of Medicine. Started Sep 2008; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Congenital Hypogonadotropic Hypogonadism (CHH)
Beyond the preview
Go deeper on NCT01454011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01454011.